BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 14678389)

  • 1. Investigation of sequential mitomycin C and photodynamic therapy in a mitomycin-resistant bladder cancer cell-line model.
    French AJ; Datta SN; Allman R; Matthews PN
    BJU Int; 2004 Jan; 93(1):156-61. PubMed ID: 14678389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of photodynamic therapy in combination with mitomycin C on a mitomycin-resistant bladder cancer cell line.
    Datta SN; Allman R; Loh C; Mason M; Matthews PN
    Br J Cancer; 1997; 76(3):312-7. PubMed ID: 9252197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitomycin C-induced cell cycle arrest enhances 5-aminolevulinic acid-based photodynamic therapy for bladder cancer.
    Nakayama T; Nozawa N; Kawada C; Yamamoto S; Ishii T; Ishizuka M; Namikawa T; Ogura SI; Hanazaki K; Inoue K; Karashima T
    Photodiagnosis Photodyn Ther; 2020 Sep; 31():101893. PubMed ID: 32592910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical characterization of a mitomycin C-resistant human bladder cancer cell line.
    Singh SV; Scalamogna D; Xia H; O'Toole S; Roy D; Emerson EO; Gupta V; Zaren HA
    Int J Cancer; 1996 Mar; 65(6):852-7. PubMed ID: 8631603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase-1 study of sequential mitomycin C and 5-aminolaevulinic acid-mediated photodynamic therapy in recurrent superficial bladder carcinoma.
    Skyrme RJ; French AJ; Datta SN; Allman R; Mason MD; Matthews PN
    BJU Int; 2005 Jun; 95(9):1206-10. PubMed ID: 15892802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical mechanism of cross-resistance to paclitaxel in a mitomycin c-resistant human bladder cancer cell line.
    Bleicher RJ; Xia H; Zaren HA; Singh SV
    Cancer Lett; 2000 Mar; 150(2):129-35. PubMed ID: 10704734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of photodynamic therapy on rat urinary bladder with orthotopic urothelial carcinoma.
    Grönlund-Pakkanen S; Wahlfors J; Talja M; Kosma VM; Pakkanen TM; Ala-Opas M; Alhava E; Moore RB
    BJU Int; 2003 Jul; 92(1):125-30. PubMed ID: 12823396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminolevulinic acid for photodynamic therapy of bladder carcinoma cells.
    Bachor R; Reich E; Rück A; Hautmann R
    Urol Res; 1996; 24(5):285-9. PubMed ID: 8931293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photodynamic therapy for superficial bladder cancer under local anaesthetic.
    Shackley DC; Briggs C; Gilhooley A; Whitehurst C; O'Flynn KJ; Betts CD; Moore JV; Clarke NW
    BJU Int; 2002 May; 89(7):665-70. PubMed ID: 11966622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of cross-resistance to cisplatin in a mitomycin C-resistant human bladder cancer cell line.
    Singh SV; Xu BH; Jani JP; Emerson EO; Backes MG; Rihn C; Scalamogna D; Stemmler N; Specht S; Blanock K
    Int J Cancer; 1995 May; 61(3):431-6. PubMed ID: 7729958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a human bladder cancer cell line selected for resistance to mitomycin C.
    Xu BH; Gupta V; Singh SV
    Int J Cancer; 1994 Sep; 58(5):686-92. PubMed ID: 8077054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of increased sensitivity to etoposide in a mitomycin C-resistant human bladder cancer cell line.
    Xia H; Bleicher RJ; Gupta V; Zaren HA; Singh SV
    Int J Cancer; 1997 Mar; 70(5):606-11. PubMed ID: 9052763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective randomized trial of hexylaminolevulinate photodynamic-assisted transurethral resection of bladder tumour (TURBT) plus single-shot intravesical mitomycin C vs conventional white-light TURBT plus mitomycin C in newly presenting non-muscle-invasive bladder cancer.
    O'Brien T; Ray E; Chatterton K; Khan MS; Chandra A; Thomas K
    BJU Int; 2013 Dec; 112(8):1096-104. PubMed ID: 24053153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inhibition of ferrochelatase enhances 5-aminolevulinic acid-based photodynamic action for prostate cancer.
    Fukuhara H; Inoue K; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J; Shuin T
    Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):399-409. PubMed ID: 24284092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photodynamic therapy of bladder cancer cell lines.
    Datta SN; Allman R; Loh CS; Mason M; Matthews PN
    Br J Urol; 1997 Sep; 80(3):421-6. PubMed ID: 9313661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The natural flavonoid silybin improves the response to Photodynamic Therapy of bladder cancer cells.
    Gándara L; Sandes E; Di Venosa G; Prack Mc Cormick B; Rodriguez L; Mamone L; Batlle A; Eiján AM; Casas A
    J Photochem Photobiol B; 2014 Apr; 133():55-64. PubMed ID: 24705371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-aminolevulinic acid mediated photodynamic therapy inhibits survival activity and promotes apoptosis of A375 and A431 cells.
    Cai J; Zheng Q; Huang H; Li B
    Photodiagnosis Photodyn Ther; 2018 Mar; 21():257-262. PubMed ID: 29309850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the cellular molecular stress responses after treatments used in bladder cancer.
    Shackley DC; Haylett A; Whitehurst C; Betts CD; O'Flynn K; Clarke NW; Moore JV
    BJU Int; 2002 Dec; 90(9):924-32. PubMed ID: 12460358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of hypoxia and pH on aminolaevulinic acid-induced photodynamic therapy in bladder cancer cells in vitro.
    Wyld L; Reed MW; Brown NJ
    Br J Cancer; 1998 May; 77(10):1621-7. PubMed ID: 9635837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of the effect of 5-aminolevulinic acid-based photodynamic therapy by simultaneous hyperthermia.
    Yanase S; Nomura J; Matsumura Y; Nagai K; Kinoshita M; Nakanishi H; Ohnishi Y; Tokuda T; Tagawa T
    Int J Oncol; 2005 Jul; 27(1):193-201. PubMed ID: 15942660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.